EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
91 hedge funds and large institutions have $188M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 94 → 91 (-3)
25% less capital invested
Capital invested by funds: $252M → $188M (-$64.1M)
Holders
91
Holding in Top 10
6
Calls
$666K
Puts
$1K
Top Buyers
| 1 | +$3.09M | |
| 2 | +$1.97M | |
| 3 | +$1.92M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.45M |
| 5 |
CA
CHI Advisors
New York
|
+$1.2M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$4.1M | |
| 3 | -$3.31M | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$525K |
| 5 |
D.E. Shaw & Co
New York
|
-$499K |